Clinical and translational research

Researchers at Dell Medical School improve patient and public health through clinical and translational science.

sdfsdfsd

New and promising cures, treatments, devices and diagnostics are studied intensely in clinical trials with the generous participation of patients and healthy volunteers. In tandem, observations from the lab, clinic and community inform and refine how biomedical research is conducted.

The result is efficient, comprehensive science; better treatments for rare, chronic and complex conditions; and patient care backed by the latest advances in medicine.

Clinical trials placeholder (There will be a XF here)

gdfgsdf

Clinical trials

Dell Med physicians and researchers conduct a range of clinical trials to find new and safe ways to prevent, treat and cure diseases and other health conditions — in partnership with patients and volunteers.

Translational research

Dell Med’s Health Transformation Research Institute provides leadership and infrastructure to support robust, innovative and world-class clinical and late-stage translational research. The institute helps investigators overcome scientific and operational bottlenecks — and cut the time it takes to develop and share new treatments and public health measures.

Technology innovation and commercialization

Students, researchers and innovators use the University’s vibrant innovation ecosystem to create new technologies that improve how healthcare is delivered and experienced.

Dell Med’s Office of Innovation and Entrepreneurship leads programs that accelerate the translation of medical innovation to healthcare at scale. Established and aspiring entrepreneurs receive mentorship, funding and industry guidance to develop their ideas into business-ready solutions with real-world clinical impact.

To train and develop future healthcare innovators, the Cockrell School of Engineering and Dell Med lead the Clinical Biodesign Program, which pairs medical students with graduate-level engineers to collaboratively identify unmet clinical needs and design innovative solutions with commercial viability.

Discovery to Impact, UT's technology development and commercialization office, brings research discoveries to the marketplace, launches startups and connects innovators with established businesses and industry partners. 

A healthcare professional is seen applying a transcranial magnetic stimulation (TMS) device to a patient's head in a clinical setting. The patient is lying back with their head supported by a pillow, while the practitioner carefully positions the device. The environment is bright and modern, suggesting a medical or research facility. No visible text or numbers are present on the device or in the scene.

Department of Defense funds UT clinical trial of drug-free postpartum depression treatment

asdf

Get Better Sleep With Ultrasound Patch That Boosts REM Rest

asdf

Drug Trial for Rare Fetal Blood Disease Shows Promise for Less Invasive Approach